![David Kideckel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 10 080 $ in data 31/07/2026
David M.
Kideckel is the founder of Kideckel Advisory Group, Inc., founded in 2021, where the title held is President & Chief Executive Officer.
Current jobs include Executive Chairman at Pharmadrug, Inc. starting in 2025; Director at Kane Biotech, Inc. starting in 2025; Chief Financial Officer & Director at Rakovina Therapeutics, Inc. starting in 2025; and EVP, Head-Strategy & Corporate Development at Delta 9 Cannabis, Inc. starting in 2021.
Former jobs include Analyst & Managing Director at ATB Cormark Capital Markets Inc. from 2018 to 2021; Director of Equity Research at Beacon Securities Limited from 2017 to 2018; Principal at Origin Merchant Partners from 2022 to 2023; and Senior VP, Head-Corporate Development & Strategic at IntelGenx Technologies Corp.
Education includes an MBA from Rotman School of Management and a doctorate from the University of Toronto.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PHARMADRUG, INC. 1,03% | 09/10/2025 | 1.380.000 ( 1,03% ) | 8 280 $ | 31/07/2026 |
| 29/07/2025 | 20.000 ( 0,09% ) | 1 800 $ | 31/07/2026 | |
KANE BIOTECH INC. -.--% | 28/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HUMBLE GROW CO. | Corporate Officer/Principal | 16/08/2021 |
| PHARMADRUG INC. | Presidente | 27/02/2024 |
| RAKOVINA THERAPEUTICS INC. | Direttore Finanziario/CFO | 01/05/2025 |
| KANE BIOTECH INC. | Direttore/Membro del Consiglio | 25/06/2025 |
| Società | Posizione | Fine |
|---|---|---|
Origin Merchant Partners
 Origin Merchant Partners Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/01/2023 |
ATB Cormark Capital Markets Inc.
 ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/08/2021 |
Beacon Securities Ltd.
 Beacon Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Direttore della Ricerca - Azioni | 01/10/2018 |
| INTELGENX TECHNOLOGIES CORP. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Kane Biotech, Inc.
 Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATB Cormark Capital Markets Inc.
ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Securities Ltd.
Beacon Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
IntelGenx Technologies Corp.
 IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
Origin Merchant Partners
Origin Merchant Partners Investment Banks/BrokersFinance Provides investment banking services | Finance |
Delta 9 Cannabis, Inc.
 Delta 9 Cannabis, Inc. Wholesale DistributorsDistribution Services Wholesales and retails cannabis products | Distribution Services |
Pharmadrug, Inc.
 Pharmadrug, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development of cannabis-infused edible products and oil extracts | Health Technology |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
